Internal Medicine, Cardiovascular Disease · Pampa, TX
NPI
1598730897
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
104 E 30th Ave
Pampa, TX, 79065
Phone (806) 665-0815
Groups this clinician bills Medicare through
Medicare paid, 2024
$144K
4,309 services
Medicare patients, 2024
361
Average age 77
Drug cost, 2024
$1.2M
9,030 prescriptions
Company payments, 2025
$72.51
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laxmichand Kamnani was code 99214 (office e&m - established), 544 times for 184 patients. In total Laxmichand Kamnani billed 4,309 services in 64 codes, and Medicare paid $144K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 544 | 184 | $83.36 | $45K |
| 93010 Electrocardiogram | Facility | 297 | 203 | $6.07 | $1,804 |
| 36415 Venipuncture Blood Collection | Office | 294 | 177 | $8.65 | $2,543 |
| 93306 Echocardiography (TTE/TEE) | Facility | 236 | 220 | $48.88 | $12K |
| 93000 Electrocardiogram | Office | 162 | 131 | $9.52 | $1,542 |
| 93298 External Electrocardiographic Monitoring | Office | 152 | 25 | $39.51 | $6,006 |
| 93016 Electrocardiogram | Facility | 131 | 130 | $15.25 | $1,998 |
| 93018 Electrocardiogram | Facility | 131 | 130 | $10.08 | $1,321 |
| 78452 Myocardial Perfusion Scan | Facility | 129 | 128 | $53.20 | $6,863 |
| 93288 External Electrocardiographic Monitoring | Office | 83 | 48 | $34.29 | $2,846 |
| 99232 Hospital E&M - Subsequent | Facility | 74 | 31 | $59.18 | $4,379 |
| 99233 Hospital E&M - Subsequent | Facility | 44 | 21 | $91.16 | $4,011 |
| 99238 Hospital Discharge Management | Facility | 43 | 35 | $62.14 | $2,672 |
| 99215 Office E&M - Established | Office | 38 | 37 | $131.70 | $5,004 |
| 99222 Hospital E&M - Initial | Facility | 28 | 25 | $91.97 | $2,575 |
By year: 2022 $184K for 2,847 services; 2023 $176K for 3,107 services; 2024 $144K for 4,309 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 294 | 177 | $8.65 | $2,543 |
Medicare prescription drug claims, 2024
In 2024, the drug Laxmichand Kamnani prescribed most often to Medicare patients was Carvedilol, with 701 prescriptions and refills. In total Laxmichand Kamnani wrote 9,030 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carvedilol Generic | 701 | 1,069 | 149 | $3,042 |
| Atorvastatin Calcium Generic | 443 | 852 | 99 | $2,654 |
| Potassium Chloride Generic | 433 | 723 | 86 | $3,613 |
| Metoprolol Succinate Generic | 416 | 739 | 80 | $4,660 |
| Losartan Potassium Generic | 407 | 689 | 90 | $2,886 |
| Rosuvastatin Calcium Generic | 376 | 733 | 82 | $3,370 |
| Amlodipine Besylate Generic | 352 | 547 | 74 | $1,278 |
| Levothyroxine Sodium Generic | 341 | 508 | 58 | $1,453 |
| Pantoprazole Sodium Generic | 323 | 511 | 68 | $1,816 |
| Spironolactone Generic | 316 | 445 | 57 | $1,448 |
| Eliquis Apixaban | 285 | 347 | 47 | $195K |
| Entresto Sacubitril/Valsartan | 282 | 347 | 50 | $225K |
| Jardiance Empagliflozin | 217 | 280 | 47 | $159K |
| Clopidogrel Clopidogrel Bisulfate | 195 | 323 | 35 | $1,157 |
| Amiodarone Hcl Generic | 163 | 217 | 35 | $2,208 |
Brand drugs: 1,780 claims; generic drugs: 7,216 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laxmichand Kamnani $72.51 ($72.51 in general payments such as food, travel and fees) from 3 companies. The largest payer was Biotronik Inc. with $30.45.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.